Bunnage Mark E.

Vertex Pharmaceuticals Inc · EVP

Bunnage Mark E. is listed in public filings as officer: EVP, Chief Scientific Officer. This Bunnage Mark E. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Vertex Pharmaceuticals Inc (VRTX). Investors use Bunnage Mark E.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Vertex Pharmaceuticals IncVRTX$15k33 sharesSellMay 15, 2026$453.45--